Conservest Capital Advisors’s Fractyl Health GUTS Stock Holding History

Conservest Capital Advisors’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$50.9K	Hold	64,118	–	–	﹤0.01%	131
2026 Q1	$29.4K	Hold	64,118	–	–	﹤0.01%	126
2025 Q4	$141K	Hold	64,118	–	–	0.01%	130
2025 Q3	$102K	Hold	64,118	–	–	0.01%	125
2025 Q2	$104K	Hold	64,118	–	–	0.01%	120
2025 Q1	$76.3K	Hold	64,118	–	–	0.01%	108
2024 Q4	$132K	Buy	+64,118	New	+$149K	0.01%	107

Other funds holding GUTS

Accredited Investors Edina, Minnesota $2.31B AUM 33.7% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Phraction Management Colchester, Connecticut $596M AUM 36.77% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

BCM

Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return

JWCA

J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return

TFM

TFC Financial Management Boston, Massachusetts $902M AUM 21.74% 1-Year Est. Return

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

Conservest Capital Advisors's GUTS Position: Q2 2026 in Review

Conservest Capital Advisors held its Fractyl Health (GUTS) position steady in Q2 2026 at 64,118 shares worth $50.9K. The position accounts for ﹤0.01% of the portfolio, ranked #131.

Conservest Capital Advisors first reported a position in GUTS in Q4 2024 and has held it in 7 quarters since. The position peaked at $141K in Q4 2025. 13 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

Conservest Capital Advisors held 64,118 shares of Fractyl Health worth $50.9K as of Q2 2026.
Conservest Capital Advisors left its Fractyl Health share count unchanged in Q2 2026.
Fractyl Health made up ﹤0.01% of Conservest Capital Advisors's portfolio in Q2 2026, its #131 holding.
Conservest Capital Advisors first reported a position in Fractyl Health in Q4 2024 and has held it in 7 quarters since.
Conservest Capital Advisors's Fractyl Health position peaked at $141K in Q4 2025.
13 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Conservest Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.